Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 202

Sort by

Sort Order Select

Journal Articles

Utilization of Investigations for Neurotoxicity in CD19 and BCMA CART Recipients

Lauren N Scott, William Wesson, Pilar Thangwaritorn, Raeef L Rahman, Forat Lutfi, Marc Hoffmann, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Al-Ola Abdallah, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Mahdi Nashatizadeh, Nausheen Ahmed

Blood (2024) 144 (Supplement 1): 389.

https://doi.org/10.1182/blood-2024-205983

Published: 2024

Journal Articles

Comparative Safety and Efficacy of Ciltacabtagene Autoleucel and Idecabtagene Vicleucel CAR T-Cell Therapies in Relapsed or Refractory Multiple Myeloma

Doris K. Hansen, Lauren C. Peres, Danai Dima, Alicia Richards, Leyla O. Shune, Aimaz Afrough, Shonali Midha, Binod Dhakal, Mehmet H. Kocoglu, Shebli Atrash, Chris Ferreri, Omar Castaneda, James A Davis, Evguenia Ouchveridze, Joseph P. McGuirk, Charlotte B Wagner, Radhika Bansal, Patrick Costello, Kinaya Smith, Alex Lieberman-Cribbin, Gabriel De Avila, Sneha Purvey, Hitomi Hosoya, Lekha Mikkilineni, Laura B. Oswald, Gurbakhash Kaur, Oren Pasvolsky, Mahmoud R. Gaballa, Megan M Herr, Peter A. Forsberg, Murali Janakiram, Myo Htut, Sireesha Asoori, Nilesh Kalariya, Hamza Hashmi, Ran Reshef, Douglas W Sborov, Omar Nadeem, Faiz Anwer, Jack Khouri, Shahzad Raza, Djordje Atanackovic, Melissa Alsina, Ciara Louise Freeman, Frederick L. Locke, Peter M. Voorhees, Larry D Anderson, Jr., Shambavi Richard, Thomas Martin, Yi Lin, Krina K. Patel, Surbhi Sidana

Blood (2024) 144 (Supplement 1): 936.

https://doi.org/10.1182/blood-2024-194390

Published: 2024

Journal Articles

Outcomes of Elderly Patients with Relapsed Refractory Multiple Myeloma (RRMM) Treated with Teclistamab: A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium

Blood (2024) 144 (Supplement 1): 934.

https://doi.org/10.1182/blood-2024-205989

Published: 2024

Journal Articles

Efficacy of Axatilimab in the Management of Chronic Graft-Versus-Host Disease

Moazzam Shahzad, Muhammad Jawad Javed, Sohaib Irfan, Muhammad Atif Khan, Muhammad Kashif Amin, Abhinav Vyas, Sibgha Gull Chaudhary, Iqra Anwar, Maggie Nelson, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7361.

https://doi.org/10.1182/blood-2024-206262

Published: 2024

Journal Articles

Incidence, Patterns, and Outcomes of Fungal Infections in Patients with Graft Versus Host Disease Requiring Systemic Steroids Following Allogeneic Hematopoietic Cell Transplantation

Moazzam Shahzad, Zobia Farooq, Rubab Zahra, Muhammad Kashif Amin, Sudeepthi Bandikatla, Areeba Ismail, Nooria Saif, Muhammad Hamza Sadiq, Fatima Inam, Sibgha Gull Chaudhary, Iqra Anwar, Muhammad Salman Faisal, Anurag K. Singh, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7331.

https://doi.org/10.1182/blood-2024-193609

Published: 2024

Journal Articles

Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review

Moazzam Shahzad, Hana Qasim, Ben Ponvilawan, Muhammad Kashif Amin, Fizza Zulfiqar, Areeba Ismail, Muhammad Uzair Ishaq, Sohaib Irfan, Abhinav Vyas, Ibrahim Khamees, Rida Ihsan, Sibgha Gull Chaudhary, Iqra Anwar, Nausheen Ahmed, Leyla O. Shune, Al-Ola Abdallah, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7237.

https://doi.org/10.1182/blood-2024-198825

Published: 2024

Journal Articles

Efficacy of Ruxolitinib with Corticosteroids in Idiopathic Pneumonia Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience and Systematic Review

Moazzam Shahzad, Muhammad Atif Khan, Muhammad Kashif Amin, Zouina Sarfraz, Fizza Zulfiqar, Hana Qasim, Sibgha Gull Chaudhary, Iqra Anwar, Faiza Humayun Khan, Rajat Bansal, Kyle Brownback, Nausheen Ahmed, Sunil Abhyankar, Joseph P. McGuirk, Anurag Singh, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7380.

https://doi.org/10.1182/blood-2024-200435

Published: 2024

Journal Articles

Chimeric Antigen T-Cell (CAR-T) Therapy Versus Autologous Stem Cell Transplantation (ASCT) in Secondary Central Nervous System Lymphoma (SCNSL): A Multicenter Retrospective Analysis

Joseph G Bennett, Kamen Kossow, Leah Diebolt, Nicole Twardowski, Jianzheng Wu, Dinesh Pal Mudaranthakam, Shaun DeJarnette, Brian Hess, James A Davis, Al-Ola Abdallah, Nausheen Ahmed, Joseph P. McGuirk, Marc Hoffmann

Blood (2024) 144 (Supplement 1): 6556.

https://doi.org/10.1182/blood-2024-201728

Published: 2024

Journal Articles

Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis

Blood (2024) 144 (Supplement 1): 7242.

https://doi.org/10.1182/blood-2024-206536

Published: 2024

Journal Articles

Socioeconomic Disparities in Allogeneic Hematopoietic Cell Transplant Outcomes

Moazzam Shahzad, Zouina Sarfraz, Ben Ponvilawan, Muhammad Kashif Amin, Ankita Gupta, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Leyla O. Shune, Joseph P. McGuirk, Mehdi Hamadani, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2024-194451

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Sibgha Gull Chaudhary, Moazzam Shahzad, Kayla Pfannenstiell, Muhammad Kashif Amin, Amir Kasaeian, Muhammad Fareed Khalid, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2024-202271

Published: 2024

Journal Articles

Long-Term Outcomes of Hyperbaric Oxygen Pretreatment in Autologous Hematopoietic Stem Cell Transplantation: A Pilot Clinical Trial

Vinny Lococo, Maire Okoniewski, Joseph P. McGuirk, Leyla O. Shune, Anurag K. Singh, Sunil Abhyankar, Omar Aljitawi, Haitham Abdelhakim

Blood (2024) 144 (Supplement 1): 7115.

https://doi.org/10.1182/blood-2024-208548

Published: 2024

Journal Articles

Outcomes of Melphalan Versus Busulfan with Fludarabine Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Abat Khan, Muhammad Kashif Amin, Gohar Rehman, Umar Akram, Kainat Nihar, Muhammad Uzair Ishaq, Areeba Ismail, Muhammad Hamza Sadiq, Sheena Shamoon, Muhammad Shaheer Mannan, Pramod Singh, Abdul Rafae Faisal, Sibgha Gull Chaudhary, Iqra Anwar, Maggie Nelson, Haitham Abdelhakim, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7426.

https://doi.org/10.1182/blood-2024-199400

Published: 2024

Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cells Haploidentical Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Gohar Rehman, Abat Khan, Muhammad Kashif Amin, Muhammad Uzair Ishaq, Umar Akram, Muhammad Hamza Sadiq, Umar Iqbal Javid Iqbal Choudhary, Sheena Shamoon, Bilal Yasin Khan, Sibgha Gull Chaudhary, Iqra Anwar, Anurag Singh, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7425.

https://doi.org/10.1182/blood-2024-199357

Published: 2024

Journal Articles

Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Bone Marrow Transplantation

Sibgha Gull Chaudhary, Moazzam Shahzad, Iqra Anwar, Sohaib Irfan, Muhammad Kashif Amin, Matthew McGuirk, Shaun DeJarnette, Nausheen Ahmed, Al-Ola Abdallah, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7424.

https://doi.org/10.1182/blood-2024-198378

Published: 2024

Journal Articles

Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine for Myeloablative Conditioning in Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplant- a Systematic Review and Meta-Analysis

Moazzam Shahzad, Abat Khan, Muhammad Kashif Amin, Pramod Singh, Umar Akram, Kainat Nihar, Muhammad Uzair Ishaq, Areeba Ismail, Salman Sani, Rubab Zahra, Usman Shahbaz, Javeria Shahani, Fatima Akram, Anmolpreet Kaur, Sibgha Gull Chaudhary, Iqra Anwar, Maggie Nelson, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7284.

https://doi.org/10.1182/blood-2024-202593

Published: 2024

Journal Articles

Absolute Lymphocyte Count As a Predictor of Safety and Efficacy Post CART for Multiple Myeloma and B Cell Malignancies

Raeef L Rahman, Jianzheng Wu, Lauren N Scott, William Wesson, Razan Mansour, Aung M. Tun, Marc Hoffmann, Al-Ola Abdallah, Dinesh Pal Mudaranthakam, Joseph P. McGuirk, Nausheen Ahmed, Forat Lutfi

Blood (2024) 144 (Supplement 1): 7099.

https://doi.org/10.1182/blood-2024-205978

Published: 2024

Journal Articles

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Blood (2024) 144 (Supplement 1): 7098.

https://doi.org/10.1182/blood-2024-207398

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes

Muhammad Umair Mushtaq, Aleenah Mohsin, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Kayla Pfannenstiell, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 7902.

https://doi.org/10.1182/blood-2024-200443

Published: 2024

Journal Articles

Impact of Obesity on Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation

Moazzam Shahzad, Aleenah Mohsin, Aqeeb Ur Rehman, Sohaib Irfan, Muhammad Atif Khan, Muhammad Kashif Amin, Matthew McGuirk, Sibgha Gull Chaudhary, Faiza Humayun Khan, Iqra Anwar, Nausheen Ahmed, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7421.

https://doi.org/10.1182/blood-2024-193485

Published: 2024

NARROW

Utilization of Investigations for Neurotoxicity in CD19 and BCMA CART Recipients

Comparative Safety and Efficacy of Ciltacabtagene Autoleucel and Idecabtagene Vicleucel CAR T-Cell Therapies in Relapsed or Refractory Multiple Myeloma

Outcomes of Elderly Patients with Relapsed Refractory Multiple Myeloma (RRMM) Treated with Teclistamab: A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium

Efficacy of Axatilimab in the Management of Chronic Graft-Versus-Host Disease

Incidence, Patterns, and Outcomes of Fungal Infections in Patients with Graft Versus Host Disease Requiring Systemic Steroids Following Allogeneic Hematopoietic Cell Transplantation

Second Primary Malignancies after CAR T-Cell Therapy: A Systemic Review

Efficacy of Ruxolitinib with Corticosteroids in Idiopathic Pneumonia Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience and Systematic Review

Chimeric Antigen T-Cell (CAR-T) Therapy Versus Autologous Stem Cell Transplantation (ASCT) in Secondary Central Nervous System Lymphoma (SCNSL): A Multicenter Retrospective Analysis

Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis

Socioeconomic Disparities in Allogeneic Hematopoietic Cell Transplant Outcomes

Sociodemographic and Patient-Related Determinants of Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Long-Term Outcomes of Hyperbaric Oxygen Pretreatment in Autologous Hematopoietic Stem Cell Transplantation: A Pilot Clinical Trial

Outcomes of Melphalan Versus Busulfan with Fludarabine Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cells Haploidentical Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis

Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Bone Marrow Transplantation

Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine for Myeloablative Conditioning in Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplant- a Systematic Review and Meta-Analysis

Absolute Lymphocyte Count As a Predictor of Safety and Efficacy Post CART for Multiple Myeloma and B Cell Malignancies

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes

Impact of Obesity on Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only